USPTO serial 87202055
Serial No. 87202055
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 21, 2018
- Examiner
- DOMBROW, COLLEEN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active. Follow Madrid and USPTO deadlines for the next renewal cycle.
Need help with Serial No. 87202055?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
94300 Vincennes, FR
94300 Vincennes, FR
Paris, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas J. Romano
Thomas J. Romano Kolitch Romano Dascenzo Gates LLC621 SW Morrison Street #1100Portland, OR 97205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Surgical implant comprising, natural and biologic living tissue valves for use in the repair of cardiac defects; surgical implants comprised of living tissue; aortic, mitral or tricuspid heart valves comprising, natural and biologic living tissue valves for use in the repair of cardiac defects; natural or biological valves for implantation | ACTIVE | — |
| 010 | Stent and stented valve delivery systems; stent and stented valve loading units, and parts and fittings therefor; Stent and stent valve loading units, and parts and fittings therefor sold as a unit, namely, devices for preparing stents and stent valves for implantation; stent and stented valve retrieval units, and parts and fittings therefor sold as a unit, namely, devices for retrieving stents and stent valves after implantation; artificial valves and artificial cardiac valves for use in the repair of cardiac defects, and parts and fittings therefore sold together as a unit; stents and parts and fittings therefore sold together as a unit; artificial stents and parts and fittings therefore sold together as a unit; cardiac stents and parts and fittings therefore sold together as a unit; surgical apparatus and instruments for medical and veterinary use in cardiac valve replacement procedures and parts and fittings therefore sold together as a unit; surgical apparatus and instruments for medical and veterinary use in aortic, mitral or tricuspid valve repair and replacement procedures and parts and fittings therefore sold together as a unit; aortic, mitral or tricuspid valve replacement stents and parts and fittings therefore sold together as a unit; catheters, balloon catheters, pigtail catheters and parts and fittings therefore sold together as a unit; catheter guidance systems being comprised of medical guidewires; guide wires for catheters and pigtail catheters, and parts and fittings therefore sold together as a unit; flexible and non-flexible tips and tip ends for catheters; catheter delivery systems comprising one or more stents, valves, balloons, stent retaining mechanisms, stent release mechanisms, and coolant and parts and fittings therefore sold together as a unit; catheter handles for catheter apparatus, and parts and fittings therefore sold together as a unit; flexible and non-flexible cartridges for catheter delivery systems, and parts and fittings therfor sold together as a unit; cartridges for catheters, and parts and fittings therfor sold together as a unit; cartridges for catheter delivery systems comprising of one or more of a stent, valve, balloon, stent retaining mechanism, stent release mechanism, and coolant, and parts and fittings therefore sold together as a unit; and structural parts for all of the foregoing goods; implantable artificial heart valves, and implantable heart valve delivery systems comprised of artificial cardiac valves for use in heart valve replacements; medical, surgical and orthopedic artificial implants; medical device for percutaneous intraluminal emplacement of artificial heart valves; medical apparatus and instruments for use in endovascular procedures; cardiovascular prostheses, implantation systems comprised of artificial surgical implants for use with artificial valves for implantation; surgical tissues, namely, surgical implants comprising artificial material | ACTIVE | — |
| 042 | [ Science and technology services, namely, scientific research; Scientific and technological services, namely, research and design in the field of artificial heart valves; design of medical devices; research and development of medical devices; scientific and technological services, namely, scientific research relating to aortic, mitral or tricuspid valve replacement stents and parts and fittings therefor; Design of aortic, mitral or tricuspid valve replacement stents and parts and fittings therefor; scientific and technological services, namely, scientific research relating to catheters, balloon catheters, pigtail catheters and parts and fittings therefor, catheter guidance systems, guide wires for catheters and pigtail catheters, and parts and fittings therefor, flexible and non-flexible tips and tip ends for catheter delivery systems, and parts and fittings therefor, tips and tip ends for catheter delivery systems, comprising of one or more of a stent, valve, balloon, stent retaining mechanism, stent release mechanism and coolant, and parts and fittings therefor, catheter handles comprising of multiple parts for catheter apparatus, and parts and fittings therefor, flexible and non-flexible cartridges for catheter delivery systems, and parts and fittings therefor, cartridges for catheter delivery systems comprising of one or more of a stent, valve, balloon, stent retaining mechanism, stent release mechanism and coolant, and parts and fittings therefor, and structural parts for all of the foregoing goods; Design of catheters, balloon catheters, pigtail catheters and parts and fittings therefor, catheter guidance systems, guide wires for catheters and pigtail catheters, and parts and fittings therefor, flexible and non-flexible tips and tip ends for catheter delivery systems, and parts and fittings therefor, tips and tip ends for catheter delivery systems, comprising of one or more of a stent, valve, balloon, stent retaining mechanism, stent release mechanism and coolant, and parts and fittings therefor, catheter handles comprising of multiple parts for catheter apparatus, and parts and fittings therefor, flexible and non-flexible cartridges for catheter delivery systems, and parts and fittings therefor, cartridges for catheter delivery systems comprising of one or more of a stent, valve, balloon, stent retaining mechanism, stent release mechanism and coolant, and parts and fittings therefor, and structural parts for all of the foregoing goods; research and development of medical products, research and development in the field of cardiovascular prostheses and implantation systems ] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 6, 2025 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Jun 6, 2025 | 8.PR | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | — |
| Jun 6, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 18, 2025 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Aug 21, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 19, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 19, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 19, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 19, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 19, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 21, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 17, 2018 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Jul 10, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 11, 2018 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Jun 11, 2018 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Dec 12, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 17, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 17, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 27, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 11, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 21, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 21, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 15, 2017 | ALIE | ASSIGNED TO LIE | — |
| Jul 21, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 24, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 24, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 24, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 24, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 19, 2016 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Oct 18, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 17, 2016 | NWAP | NEW APPLICATION ENTERED | — |